The role of substance P in myocardial dysfunction during ischemia and reperfusion

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Impairment of myocardial contraction ('myocardial stunning') occurs during reperfusion after short ischemic periods. Substance P (SP) is widely distributed in heart and can be released by various stimuli including myocardial hypoxia. Our previous study shows SP has a negative inotropic effect in guinea pig heart. The objective of this study was to investigate whether SP contributes to the myocardial stunning after brief global ischemia. Guinea pig hearts in a Langendorff preparation were subjected to 15 min of global ischemia followed by 60 min reperfusion. Experiments were performed without and with pretreatment with neurokinin-1 (NK1) receptor antagonists, spantide (10-6 M) or CP-99,994-01 (10-6 M) in order to study the role of SP. Experiments were also performed in hearts which were perfused with atropine, phentolamine, and nadolol (10-6 M each) to examine the role of neurotransmitters and autonomic receptors. A group of hearts obtained from capsaicin-pretreated guinea pigs was also investigated. Left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), heart rate, and perfusion pressure were monitored. At the end of reperfusion, the LVDP of control hearts recovered to only 55 ± 6% (± SEM) of preischemic baseline and the LVEDP increased significantly (P > 0.05). With pretreatment with spantide or CP-99,994-01, LVDP recovered to 88 ± 2% or 78 ± 2% of the preischemic baseline, respectively. The LVEDP of these hearts was not different from preischemic baseline and much smaller than in control hearts. There were no differences in heart rate and perfusion pressure compared to baseline among all groups. Similar results were obtained in hearts perfused with autonomic blockers. However, recoveries of LVDP and LVEDP were faster in hearts perfused with autonomic blockers during the first 10 min of reperfusion. Pretreatment with capsaicin also significantly improved recovery of LVDP and LVEDP. In conclusion, substance P is involved in postischemic myocardial dysfunction and neurokinin-l receptors mediate this action. The NK1 receptor antagonists may be useful in prevention of 'myocardial stunning'.

Original languageEnglish (US)
Pages (from-to)400-407
Number of pages8
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume353
Issue number4
StatePublished - Apr 9 1996

Fingerprint

Substance P
Reperfusion
Ischemia
Ventricular Pressure
Myocardial Stunning
Blood Pressure
Neurokinin-1 Receptor Antagonists
Guinea Pigs
Capsaicin
Perfusion
Heart Rate
Nadolol
Myocardial Contraction
Pressure
Neurotransmitter Receptor
Phentolamine
Atropine

Keywords

  • Ischemia reperfusion
  • Myocardial stunning
  • Substance P

ASJC Scopus subject areas

  • Pharmacology

Cite this

The role of substance P in myocardial dysfunction during ischemia and reperfusion. / Chiao, Hsi; Caldwell, Robert William.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 353, No. 4, 09.04.1996, p. 400-407.

Research output: Contribution to journalArticle

@article{2a63a654638848c29d8559ee66f5e4a5,
title = "The role of substance P in myocardial dysfunction during ischemia and reperfusion",
abstract = "Impairment of myocardial contraction ('myocardial stunning') occurs during reperfusion after short ischemic periods. Substance P (SP) is widely distributed in heart and can be released by various stimuli including myocardial hypoxia. Our previous study shows SP has a negative inotropic effect in guinea pig heart. The objective of this study was to investigate whether SP contributes to the myocardial stunning after brief global ischemia. Guinea pig hearts in a Langendorff preparation were subjected to 15 min of global ischemia followed by 60 min reperfusion. Experiments were performed without and with pretreatment with neurokinin-1 (NK1) receptor antagonists, spantide (10-6 M) or CP-99,994-01 (10-6 M) in order to study the role of SP. Experiments were also performed in hearts which were perfused with atropine, phentolamine, and nadolol (10-6 M each) to examine the role of neurotransmitters and autonomic receptors. A group of hearts obtained from capsaicin-pretreated guinea pigs was also investigated. Left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), heart rate, and perfusion pressure were monitored. At the end of reperfusion, the LVDP of control hearts recovered to only 55 ± 6{\%} (± SEM) of preischemic baseline and the LVEDP increased significantly (P > 0.05). With pretreatment with spantide or CP-99,994-01, LVDP recovered to 88 ± 2{\%} or 78 ± 2{\%} of the preischemic baseline, respectively. The LVEDP of these hearts was not different from preischemic baseline and much smaller than in control hearts. There were no differences in heart rate and perfusion pressure compared to baseline among all groups. Similar results were obtained in hearts perfused with autonomic blockers. However, recoveries of LVDP and LVEDP were faster in hearts perfused with autonomic blockers during the first 10 min of reperfusion. Pretreatment with capsaicin also significantly improved recovery of LVDP and LVEDP. In conclusion, substance P is involved in postischemic myocardial dysfunction and neurokinin-l receptors mediate this action. The NK1 receptor antagonists may be useful in prevention of 'myocardial stunning'.",
keywords = "Ischemia reperfusion, Myocardial stunning, Substance P",
author = "Hsi Chiao and Caldwell, {Robert William}",
year = "1996",
month = "4",
day = "9",
language = "English (US)",
volume = "353",
pages = "400--407",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The role of substance P in myocardial dysfunction during ischemia and reperfusion

AU - Chiao, Hsi

AU - Caldwell, Robert William

PY - 1996/4/9

Y1 - 1996/4/9

N2 - Impairment of myocardial contraction ('myocardial stunning') occurs during reperfusion after short ischemic periods. Substance P (SP) is widely distributed in heart and can be released by various stimuli including myocardial hypoxia. Our previous study shows SP has a negative inotropic effect in guinea pig heart. The objective of this study was to investigate whether SP contributes to the myocardial stunning after brief global ischemia. Guinea pig hearts in a Langendorff preparation were subjected to 15 min of global ischemia followed by 60 min reperfusion. Experiments were performed without and with pretreatment with neurokinin-1 (NK1) receptor antagonists, spantide (10-6 M) or CP-99,994-01 (10-6 M) in order to study the role of SP. Experiments were also performed in hearts which were perfused with atropine, phentolamine, and nadolol (10-6 M each) to examine the role of neurotransmitters and autonomic receptors. A group of hearts obtained from capsaicin-pretreated guinea pigs was also investigated. Left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), heart rate, and perfusion pressure were monitored. At the end of reperfusion, the LVDP of control hearts recovered to only 55 ± 6% (± SEM) of preischemic baseline and the LVEDP increased significantly (P > 0.05). With pretreatment with spantide or CP-99,994-01, LVDP recovered to 88 ± 2% or 78 ± 2% of the preischemic baseline, respectively. The LVEDP of these hearts was not different from preischemic baseline and much smaller than in control hearts. There were no differences in heart rate and perfusion pressure compared to baseline among all groups. Similar results were obtained in hearts perfused with autonomic blockers. However, recoveries of LVDP and LVEDP were faster in hearts perfused with autonomic blockers during the first 10 min of reperfusion. Pretreatment with capsaicin also significantly improved recovery of LVDP and LVEDP. In conclusion, substance P is involved in postischemic myocardial dysfunction and neurokinin-l receptors mediate this action. The NK1 receptor antagonists may be useful in prevention of 'myocardial stunning'.

AB - Impairment of myocardial contraction ('myocardial stunning') occurs during reperfusion after short ischemic periods. Substance P (SP) is widely distributed in heart and can be released by various stimuli including myocardial hypoxia. Our previous study shows SP has a negative inotropic effect in guinea pig heart. The objective of this study was to investigate whether SP contributes to the myocardial stunning after brief global ischemia. Guinea pig hearts in a Langendorff preparation were subjected to 15 min of global ischemia followed by 60 min reperfusion. Experiments were performed without and with pretreatment with neurokinin-1 (NK1) receptor antagonists, spantide (10-6 M) or CP-99,994-01 (10-6 M) in order to study the role of SP. Experiments were also performed in hearts which were perfused with atropine, phentolamine, and nadolol (10-6 M each) to examine the role of neurotransmitters and autonomic receptors. A group of hearts obtained from capsaicin-pretreated guinea pigs was also investigated. Left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), heart rate, and perfusion pressure were monitored. At the end of reperfusion, the LVDP of control hearts recovered to only 55 ± 6% (± SEM) of preischemic baseline and the LVEDP increased significantly (P > 0.05). With pretreatment with spantide or CP-99,994-01, LVDP recovered to 88 ± 2% or 78 ± 2% of the preischemic baseline, respectively. The LVEDP of these hearts was not different from preischemic baseline and much smaller than in control hearts. There were no differences in heart rate and perfusion pressure compared to baseline among all groups. Similar results were obtained in hearts perfused with autonomic blockers. However, recoveries of LVDP and LVEDP were faster in hearts perfused with autonomic blockers during the first 10 min of reperfusion. Pretreatment with capsaicin also significantly improved recovery of LVDP and LVEDP. In conclusion, substance P is involved in postischemic myocardial dysfunction and neurokinin-l receptors mediate this action. The NK1 receptor antagonists may be useful in prevention of 'myocardial stunning'.

KW - Ischemia reperfusion

KW - Myocardial stunning

KW - Substance P

UR - http://www.scopus.com/inward/record.url?scp=0030005087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030005087&partnerID=8YFLogxK

M3 - Article

VL - 353

SP - 400

EP - 407

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 4

ER -